Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$0.95 - $4.74
Next Earnings Date
May 13 2025
Next Earnings Date
May 13 2025
Latest price
Market Cap | $47.72M |
EV | $-88.64M |
Shares Outstanding | 17.23M |
Beta | - |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $5.00 |
P/E 2025E | - |
P/Revenue 2025E | 1.33x |
Revenue | - |
EPS | - |
Operating Cash Flow | 6.40% |
Free Cash Flow | - |
Revenue | - |
EPS | 71.30% |
Operating Cash Flow | 45.10% |
Free Cash Flow | 22.00% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | -50.89% |
ROCE 2024 | -63.57% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Mural Oncology plc
MURA
Sector
Healthcare
Industry
Biotechnology
CEO
Loew, Caroline
Employees
116
Website
www.muraloncology.comIPO Date
2023-11-16
Headquarters
10 Earlsfort Terrace, Dublin D02 T380, Ireland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved